Epilepsy, Temporal Lobe trials recruiting in Arkansas

Fewer than 3 recruiting trials found.

All Epilepsy, Temporal Lobe trials nationally

Cities in Arkansas

Recruiting trials in Arkansas

• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
  NCT06422923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arkansas: Little Rock